About this trial
The purpose of this study is to determine the feasibility of capturing daily dietary intake of patients undergoing radiation therapy using a mobile food record. This is a prospective single group, non-randomized, feasibility study.
20 participants will be identified during routine clinical care visits with the study PI or co-investigators. Consent will be obtained in person during a clinic visit or using the e-consent process described in section 21.1. They will be asked to use the myCircadian Clock (mCC) app to document their dietary intake for the duration of their radiation treatment. No follow up data will be collected.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients age ≥18 starting a new course of radiation therapy for cancer treatment
Written informed consent obtained from participant and ability for participant to comply with the requirements of the study.
Stated willingness to comply with all study procedures and availability for the duration of the study
Own a smartphone or smart device
Disqualifiers
Pregnant or lactating women per self report prior to starting radiation therapy
Trial design
Single group
Treatments tested in this trial
Mobile food record using myCircadian Clock app
BehavioralParticipants will use the myCircadian Clock (mCC) app to document all dietary intake. The mCC app serves as a research-based mobile food record by capturing the food image coupled with the participant's free-text entry to self-describe the food. The participants will be asked to document all dietary intake throughout the course of their radiation therapy. All dietary intake will be tracked other than water and medications.
Treatment groups
Trial outcomes
Primary outcomes
Feasibility of completing mobile food record during radiation therapy
Investigators hypothesize that it is feasible for patients undergoing radiation therapy to comply with completing a mobile food record. Feasibility is defined as 75% of the participants completing the dietary intake on at least 80% of the days that they are undergoing radiation therapy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.